Levels of sCD40 ligand in chronic and acute coronary syndromes and its relation to angiographic extent of coronary arterial narrowing

Angiology

Volumn 61, Issue 6, 2010, Pages 567-573

  Fouad, Hanan H ^a   Al Dera, Husain ^b   Bakhoum, Sameh W ^a   Rashed, Laila A ^a   Sayed, Rehab H ^a   Rateb, Moshira A ^a   Haidara, Mohamed A ^c   Soskic, Sanja ^d   Isenovic, Esma R ^d  

^a CAIRO UNIVERSITY   (Egypt)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^c KING KHALID UNIVERSITY   (Saudi Arabia)

^d UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

acute coronary syndrome; CD40 ligand; coronary angiogram; coronary artery disease

Indexed keywords

CD40 LIGAND; CHOLESTEROL; CREATINE KINASE; CREATINE KINASE MB; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOLUBLE CD40 LIGAND; TRIACYLGLYCEROL; TROPONIN T; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; ENZYME ACTIVITY; FEMALE; HEART INFARCTION; HUMAN; ISOENZYME ANALYSIS; MALE; PATHOGENESIS; SCORING SYSTEM; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; TRIACYLGLYCEROL BLOOD LEVEL; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CD40 LIGAND; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CREATINE KINASE; CREATINE KINASE, MB FORM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TROPONIN T;

EID: 77955020141     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319709356785     Document Type: Article

References (40)

1. Fuster V., Badimon L., Badimon JJ, et al. The pathogenesis of coronary artery disease in the acute coronary syndromes. N Engl J Med. 1992 ; 326 (4). 242-250.
2. Ross R. The pathogenesis of atherosclerosis. A perspective for the 1990s. Nature. 1993 ; 362 (6423). 80-89.
3. Athyros VG, Kakafika AI, Karagiannis A., et al. Do we need to consider inflammatory markers when we treat atherosclerotic disease ? Atherosclerosis. 2008 ; 200 (1). 1-12.
4. Biasucci LM, Vitelli A., Liuzzo G., et al. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996 ; 94 (5). 874-877.
5. Moreno PR, Falk E., Palacios IF, et al. Macrophage infiltration in acute coronary syndromes: implications of plaque rupture. Circulation. 1994 ; 90 (2). 775-778.
6. Dollery CM, Mcewan JR, Henney A. Matrix metalloproteinases and cardiovascular disease. Circ Res. 1995 ; 77 (5). 863-868.
7. Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994 ; 94 (6). 2493-2503.
8. Serneri GG, Abbate R., Gori AM, et al. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation. 1992 ; 86 (3). 790-797.
9. Gregory SA, Edgington TS Tissue factor induction in human monocytes: two distinct mechanisms displayed by and different alloantigen responsive T cell clones. J Clin Invest. 1985 ; 76 (6). 2440-2445.
10. Foy TM, Arufro A., Bojorath J., et al. Immune regulation by CD40 and its ligand GP30. Annu Rev Immunol. 1996 ; 14: 591-617. Review.
11. Mach F., Schnbeck U., Sukhova GK, et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci U S A. 1997 ; 94 (5). 1931-1936.
12. Hollenbaug D., Grosmaire RS, Kullas CD, et al. The human T cell antigen gp 39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 1992 ; 11 (12). 4313-4321.
13. Grewal IS, Flavell RA The CD40 ligand. Immunol Res. 1997 ; 16 (1). 59-70.
14. Henn V., Slupsky JS, Grafe M., et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 1998 ; 351 (6667). 591-594.
15. Mach F., Schonberck U., Bonnefoy JY, et al. Activation of monocytes/ macrophage functions related to acute atheroma complication by ligation of CD40. Induction of collagenase, stromelysin and tissue factor. Circulation. 1997 ; 96 (2). 396-399.
16. Braunwald E. Unstable angina. A classification. Circulation. 1989 ; 80 (2). 410-414.
17. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., et al. Myocardial infarction and coronary deaths in the World Health Organisation MONICA project. Circulation. 1994 ; 90 (1). 583-612.
18. Ahmed WH, Bittl JH, Braunwald E. Relation between clinical presentation and angiographic findings in unstable angina pectoris, and comparison with that in stable angina. Am J Cardiol. 1993 ; 72 (7). 544-550.
19. Bakker AJ, Koelemay MJ, van Vlies B., et al. Exclusion of acute myocardial infarction. The value of measuring creatine kinase slope. Eur J Clin Chem Clin Biochem. 1995 ; 33 (6). 351-363.
20. Ambrose JA, Winters SL, Stern A., et al. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol. 1985 ; 5 (3). 609-616.
21. Ambrose JA, Israel DH Angiography in unstable angina. Am J Cardiol. 1991 ; 68 (7). 78B - 84B.
22. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology /American Heart Association task force on assessment of diagnostic and therapeutic cardiovascular procedures (subcommittee on percutaneous transluminal coronary angioplasty). J Am Coll Cardiol. 1988 ; 12 (2). 529-545.
23. Kusuoka H., Hoffman JIE. Advice on statistical analysis for Circulation Research. Circ Res. 2002 ; 91 (8). 662-671.
24. Liuzzo G., Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 1994 ; 331 (7). 417-424.
25. De Beer FC, Hind CRK, Fox KM, et al. Measurement of serum C-reactive protein concentration in myocardial ischemia and infarction. Br Heart J. 1982 ; 47 (3). 239-243.
26. Berk BC, Weintraub WS, Alexander RW Elevation of C-reactive protein in ĝ€activeĝ coronary artery disease. Am J Cardiol. 1990 ; 65 (3). 168-172.
27. Silva AR, Pacheco P., Vieira-de-Abreu A., et al. Lipid bodies in oxidized LDL-induced foam cells are leukotriene-synthesizing organelles: a MCP-1/CCL2 regulated phenomenon. Biochim Biophys Acta. 2009 ; 1791 (11). 1066-1075.
28. Takano T., Itabe H., Mori M., et al. Molecular pathology in atherosclerosis: the mechanism by which cholesteryl ester accumulates in atheromatous aorta. Yakugaku Zasshi. 2008 ; 128 (10). 1383-1401.
29. Moreno PR, Fallon JT Inflammation in acute coronary syndromes. In: Schulthesis H, Schwimmbeck P, eds. The Role of Immune Mechanisms in Cardiovascular Disease. Berlin: Springer; 1997: 213-229.
30. Aukrust P., Muller F., Ueland T., et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocytes and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation. 1999 ; 100 (6). 614-620.
31. Schnbeck U., Mach F., Sukhova GK, et al. Regulation of matrix metalloproteinases expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture ? Circ Res. 1997 ; 81 (3). 448-454.
32. Zhou L., Stordeur P., De Lavareille A., et al. CD40 engagement on endothelial cells promotes tissue factor-dependent procoagulant activity. Thromb Haemost. 1998 ; 79 (5). 1025-1028.
33. Gurfinkel EP, Scircia BM, Bozovich G., et al. Serum neopterin levels and the anigraphic extent of coronary arterial narrowing in unstable angina pectoris and in non-Q-wave acute myocardial infarction. Am J Cardiol. 1999 ; 83 (4). 515-518.
34. Auer J., Berent R., Labetanig E., et al. Serum neopterin and activity of coronary artery disease. Heart Dis. 2001 ; 3 (5). 297-301.
35. Ridker PM, Cushman M., Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997 ; 336 (14). 973-979.
36. Tatzber F., Rabl H., Koriska E., et al. Elevated serum neopterin levels in atherosclerosis. Atherosclerosis. 1991 ; 89 (2-3). 203-208.
37. Schumacher M., Eber B., Tatzber F., et al. Neopterin levels in patients with coronary artery disease. Atherosclerosis. 1992 ; 94 (1). 87-88.
38. Garca-a-Moll X., Coccolo F., Cole D., et al. Serum neopterin and complex stenosis morphology in patients with unstable angina. J Am Coll Cardiol. 2000 ; 35 (4). 956-862.
39. Lendon CL, Daviews MJ, Born GV, et al. Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis. 1991 ; 87 (1). 87-90.
40. Loree HM, Kamm RD, Stringfellow RG, et al. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res. 1992 ; 71 (4). 850-858.